AI assistant
MORGAN STANLEY — Capital/Financing Update 2011
Jun 28, 2011
29766_prs_2011-06-28_19ea2b55-199e-4753-ae05-a4830fc64a69.zip
Capital/Financing Update
Open in viewerOpens in your device viewer
| CALCULATION OF REGISTRATION FEE — Title of Each Class of Securities Offered | Maximum Aggregate Offering Price | Amount of Registration Fee |
|---|---|---|
| Performance Leveraged Upside Securities due 2012 | $5,030,000 | $583.98 |
June 2011 Pricing Supplement No. 851 Registration Statement No. 333-156423 Dated June 24, 2011 Filed pursuant to Rule 424(b)(2)
STRUCTURED INVESTMENTS
Opportunities in International Equities
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
The PLUS are senior unsecured obligations of Morgan Stanley, will pay no interest, do not guarantee any return of principal at maturity and have the terms described in the accompanying prospectus supplement for PLUS and the prospectus, as supplemented or modified by this pricing supplement. At maturity, you will receive for each stated principal amount of PLUS that you hold an amount in cash that may be greater than, equal to or less than the stated principal amount based upon the closing value of the underlying index on the valuation date. All payments on the PLUS are subject to the credit risk of Morgan Stanley.
| FINAL TERMS — Issuer: | Morgan Stanley | ||
|---|---|---|---|
| Maturity date: | July 27, 2012 | ||
| Underlying index: | Nikkei 225 Index | ||
| Aggregate principal amount: | $5,030,000 | ||
| Payment at maturity: | If the final index value is greater than the initial index value, | ||
| $1,000 + leveraged upside payment | |||
| In no event will the payment at maturity exceed the maximum payment at maturity. | |||
| If the final index value is less than or equal to the initial index value, | |||
| $1,000 × index performance factor | |||
| This amount will be less than or equal to the stated principal amount of $1,000 . | |||
| Leveraged upside payment: | $1,000 × leverage factor × index percent increase | ||
| Index percent increase: | (final index value – initial index value) / initial index value | ||
| Initial index value: | 9,678.71, which is the index closing value on the pricing date | ||
| Final index value: | The index closing value on the valuation date | ||
| Valuation date: | July 24, 2012, subject to postponement for non-index business days and certain market disruption events | ||
| Leverage factor: | 150% | ||
| Index performance factor: | final index value / initial index value | ||
| Maximum payment at maturity: | $1,150 per PLUS (115% of the stated principal amount) | ||
| Stated principal amount: | $1,000 per PLUS | ||
| Issue price: | $1,000 per PLUS | ||
| Pricing date: | June 24, 2011 | ||
| Original issue date: | June 29, 2011 (3 business days after the pricing date) | ||
| CUSIP: | 617482WB6 | ||
| ISIN: | US617482WB66 | ||
| Listing: | The PLUS will not be listed on any securities exchange. | ||
| Agent: | Morgan Stanley & Co. LLC (“MS & Co.”), a wholly-owned subsidiary of Morgan Stanley. See “Supplemental information regarding plan of distribution; conflicts of interest.” | ||
| Commissions and Issue Price: | Price to Public | Agent’s Commissions (1) | Proceeds to Issuer |
| Per PLUS | $1,000 | $10 | $990 |
| Total | $5,030,000 | $50,300 | $4,979,700 |
(1) Selected dealers and their financial advisors, which may include our affiliates, will collectively receive from the Agent, MS & Co., a fixed sales commission of $10 for each PLUS they sell. See “Supplemental information regarding plan of distribution; conflicts of interest.” For additional information, see “Plan of Distribution (Conflicts of Interest)” in the accompanying prospectus supplement for PLUS.
The PLUS involve risks not associated with an investment in ordinary debt securities. See “Risk Factors” beginning on page 8.
The Securities and Exchange Commission and state securities regulators have not approved or disapproved these securities, or determined if this pricing supplement or the accompanying prospectus supplement and prospectus is truthful or complete. Any representation to the contrary is a criminal offense.
You should read this document together with the related prospectus supplement and prospectus, each of which
can be accessed via the hyperlinks below.
EFPlaceholder Prospectus Supplement for PLUS dated December 22, 2009 EFPlaceholder Prospectus dated December 23, 2008
The PLUS are not bank deposits and are not insured or guaranteed by the Federal Deposit Insurance Corporation or any other governmental agency, nor are they obligations of, or guaranteed by, a bank.
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
Fact Sheet
The PLUS are senior unsecured obligations of Morgan Stanley, will pay no interest, do not guarantee any return of principal at maturity and have the terms described in the prospectus supplement for PLUS and the prospectus, as supplemented or modified by this pricing supplement. At maturity, an investor will receive for each stated principal amount of PLUS that the investor holds, an amount in cash that may be greater than, equal to or less than the stated principal amount based upon the closing value of the underlying index on the valuation date. The PLUS are senior notes issued as part of Morgan Stanley’s Series F Global Medium-Term Notes program. All payments on the PLUS are subject to the credit risk of Morgan Stanley.
| Key Dates — Pricing date: | Original issue date (settlement date): | Maturity date: |
|---|---|---|
| June 24, 2011 | June 29, 2011 (3 business days after the pricing date) | July 27, 2012 , subject to postponement as described below |
| Key Terms | ||
| Issuer: | Morgan Stanley | |
| Underlying index: | Nikkei 225 Index | |
| Underlying index publisher: | Nikkei Inc. | |
| Aggregate principal amount: | $5,030,000 | |
| Issue price: | $1,000 per PLUS | |
| Stated principal amount: | $1,000 per PLUS | |
| Denominations: | $1,000 per PLUS and integral multiples thereof | |
| Interest: | None | |
| Bull market or bear market PLUS: | Bull market PLUS | |
| Payment at maturity: | If the final index value is greater than the initial index value, | |
| $1,000 + leveraged upside payment | ||
| In no event will the payment at maturity exceed the maximum payment at maturity. | ||
| If the final index value is less than or equal to the initial index value, | ||
| $1,000 × index performance factor | ||
| This amount will be less than or equal to the stated principal amount of $1,000 . | ||
| Leveraged upside payment: | $1,000 × leverage factor × index percent increase | |
| Index percent increase: | (final index value – initial index value) / initial index value | |
| Leverage factor: | 150% | |
| Index performance factor: | final index value / initial index value | |
| Initial index value: | 9,678.71, which is the index closing value on the pricing date as published by the underlying index publisher. | |
| Final index value: | The index closing value on the valuation date as published by the underlying index publisher. | |
| Valuation date: | July 24, 2012, subject to postponement for non-index business days and certain market disruption events | |
| Maximum payment at maturity: | $1,150 per PLUS (115% of the stated principal amount) | |
| Postponement of maturity date: | If the scheduled valuation date is not an index business day or if a market disruption event occurs on that day so that the valuation date as postponed falls less than two business days prior to the scheduled maturity date, the maturity date of the PLUS will be postponed until the second business day following that valuation date as postponed. | |
| Risk factors: | Please see “Risk Factors” beginning on page 8 . |
June 2011 Page 2
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
| General Information | |
|---|---|
| Listing: | The PLUS will not be listed on any securities exchange. |
| CUSIP: | 617482WB6 |
| ISIN: | US617482WB66 |
| Minimum ticketing size: | $1,000 / 1 PLUS |
| Tax considerations: | Although the issuer believes that, under current law, the PLUS should be treated as a single financial contract that is an “open transaction” for U.S. federal income tax purposes, there is uncertainty regarding the U.S. federal income tax consequences of an investment in the PLUS. |
| Assuming this treatment of the PLUS is respected and subject to the discussion in “United States Federal Taxation” in the accompanying prospectus supplement for PLUS, the following U.S. federal income tax consequences should result based on current law: |
| § | A U.S. Holder should not be required to recognize taxable income over the term of the PLUS prior to maturity, other than pursuant to a sale or exchange. |
|---|---|
| § | Upon sale, exchange or settlement of the PLUS at maturity, a U.S. Holder should recognize gain or loss equal to the difference between the amount realized and the U.S. Holder’s tax basis in the PLUS. Such gain or loss should be long-term capital gain or loss if the investor has held the PLUS for more than one year. |
| On December 7, 2007, the Treasury Department and the Internal Revenue Service (the “IRS”) released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments, such as the PLUS . The notice focuses in particular on whether to require holders of these instruments to accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments; whether short-term instruments should be subject to any such accrual regime; the relevance of factors such as the exchange-traded status of the instruments and the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” regime, which very generally can operate to recharacterize certain long-term capital gain as ordinary income and impose an interest charge. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the PLUS , possibly with retroactive effect. | |
|---|---|
| Both U.S. and non-U.S. investors considering an investment in the PLUS should read the discussion under “Risk Factors” in this document and the discussion under “United States Federal Taxation” in the accompanying prospectus supplement for PLUS and consult their tax advisers regarding all aspects of the U.S. federal income tax consequences of an investment in the PLUS, including possible alternative treatments, the issues presented by the aforementioned notice and any tax consequences arising under the laws of any state, local or foreign taxing jurisdiction. | |
| Trustee: | The Bank of New York Mellon (as successor trustee to JPMorgan Chase Bank, N.A.) |
| Calculation agent: | MS & Co. |
| Use of proceeds and hedging: | The net proceeds we receive from the sale of the PLUS will be used for general corporate purposes and, in part, in connection with hedging our obligations under the PLUS through one or more of our subsidiaries. |
| On or prior to the pricing date, we, through our subsidiaries or others, hedged our anticipated exposure in connection with the PLUS by taking positions in stocks of the underlying index, futures and/or options contracts on the underlying index and component stocks of the underlying index listed on major securities markets. Such purchase activity could have increased the value of the underlying index on the pricing date, and therefore could have increased the value at which the underlying index must close on the valuation date before investors would receive at maturity a payment that exceeds the stated principal amount of the PLUS. For further information on our use of proceeds and hedging, see “Use of Proceeds and Hedging” in the accompanying prospectus supplement for PLUS. | |
| Benefit plan investor considerations: | Each fiduciary of a pension, profit-sharing or other employee benefit plan subject to the Employee Retirement Income Security Act of 1974, as amended (“ERISA”) (a “Plan”) , should consider the fiduciary standards of ERISA in the context of the Plan’s particular circumstances before authorizing an investment in the PLUS. Accordingly, among other factors, the fiduciary should consider whether the investment would satisfy the prudence and diversification requirements of ERISA and would be consistent with the documents and instruments governing the Plan. |
June 2011 Page 3
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
| In addition, we and certain of our subsidiaries and affiliates, including MS & Co., may be considered a “party in interest” within the meaning of ERISA, or a “disqualified person” within the meaning of the Internal Revenue Code of 1986, as amended (the “Code”), with respect to many Plans, as well as many individual retirement accounts and Keogh plans (also “Plans”). ERISA Section 406 and Code Section 4975 generally prohibit transactions between Plans and parties in interest or disqualified persons . Prohibited transactions within the meaning of ERISA or the Code would likely arise, for example, if the PLUS are acquired by or with the assets of a Plan with respect to which MS & Co. or any of its affiliates is a service provider or other party in interest, unless the PLUS are acquired pursuant to an exemption from the “prohibited transaction” rules. A violation of these “prohibited transaction” rules could result in an excise tax or other liabilities under ERISA and/or Code Section 4975 for such persons, unless exemptive relief is available under an applicable statutory or administrative exemption. | |
|---|---|
| The U.S. Department of Labor has issued five prohibited transaction class exemptions (“PTCEs”) that may provide exemptive relief for direct or indirect prohibited transactions resulting from the purchase or holding of the PLUS. Those class exemptions are PTCE 96-23 (for certain transactions determined by in-house asset managers), PTCE 95-60 (for certain transactions involving insurance company general accounts), PTCE 91-38 (for certain transactions involving bank collective investment funds), PTCE 90-1 (for certain transactions involving insurance company separate accounts) and PTCE 84-14 (for certain transactions determined by independent qualified professional asset managers). In addition, ERISA Section 408(b)(17) and Section 4975(d)(20) of the Code may provide an exemption for the purchase and sale of securities and the related lending transactions, provided that neither the issuer of the securities nor any of its affiliates has or exercises any discretionary authority or control or renders any investment advice with respect to the assets of the Plan involved in the transaction and provided further that the Plan pays no more, and receives no less, than “adequate consideration” in connection with the transaction (the so-called “service provider” exemption). There can be no assurance that any of these class or statutory exemptions will be available with respect to transactions involving the PLUS . | |
| Because we may be considered a party in interest with respect to many Plans, the PLUS may not be purchased, held or disposed of by any Plan, any entity whose underlying assets include “plan assets” by reason of any Plan’s investment in the entity (a “Plan Asset Entity”) or any person investing “plan assets” of any Plan, unless such purchase, holding or disposition is eligible for exemptive relief, including relief available under PTCEs 96-23, 95-60, 91-38, 90-1, 84-14 or the service provider exemption or such purchase, holding or disposition is otherwise not prohibited. Any purchaser, including any fiduciary purchasing on behalf of a Plan, transferee or holder of the PLUS will be deemed to have represented, in its corporate and its fiduciary capacity, by its purchase and holding of the PLUS that either (a) it is not a Plan or a Plan Asset Entity and is not purchasing such PLUS on behalf of or with “plan assets” of any Plan or with any assets of a governmental, non-U.S. or church plan that is subject to any federal, state, local or non-U.S. law that is substantially similar to the provisions of Section 406 of ERISA or Section 4975 of the Code (“Similar Law”) or (b) its purchase, holding and disposition are eligible for exemptive relief or such purchase, holding and disposition are not prohibited by ERISA or Section 4975 of the Code or any Similar Law. | |
| Due to the complexity of these rules and the penalties that may be imposed upon persons involved in non-exempt prohibited transactions, it is particularly important that fiduciaries or other persons considering purchasing the PLUS on behalf of or with “plan assets” of any Plan consult with their counsel regarding the availability of exemptive relief. | |
| Each purchaser and holder of the PLUS has exclusive responsibility for ensuring that its purchase, holding and disposition of the PLUS do not violate the prohibited transaction rules of ERISA or the Code or any Similar Law. The sale of any PLUS to any Plan or plan subject to Similar Law is in no respect a representation by us or any of our affiliates or representatives that such an investment meets all relevant legal requirements with respect to investments by plans generally or any particular plan, or that such an investment is appropriate for plans generally or any particular plan. | |
| However, individual retirement accounts, individual retirement annuities and Keogh plans, as well as employee benefit plans that permit participants to direct the investment of their accounts, will not be permitted to purchase or hold the PLUS if the account, plan or annuity is for the benefit of an employee of Citigroup Global Markets Inc., Morgan Stanley or Morgan Stanley Smith Barney LLC (“MSSB”) or a family member and the employee receives any compensation (such as, for example, an addition to bonus) based on the purchase of the PLUS by the account, plan or annuity. | |
| Additional considerations: | Client accounts over which Citigroup Inc., Morgan Stanley, MSSB or any of their respective subsidiaries have investment discretion are not permitted to purchase the PLUS, either directly or |
June 2011 Page 4
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
| indirectly. | |
|---|---|
| Supplemental information regarding plan of distribution; conflicts of interest: | Selected dealers, which may include our affiliates, and their financial advisors will receive from the Agent, MS & Co., a fixed sales commission of $10 for each PLUS they sell. |
| MS & Co. is our wholly-owned subsidiary. MS & Co. will conduct this offering in compliance with the requirements of FINRA Rule 5121 of the Financial Industry Regulatory Authority, Inc., which is commonly referred to as FINRA, regarding a FINRA member firm’s distribution of the securities of an affiliate and related conflicts of interest. MS & Co. or any of our other affiliates may not make sales in this offering to any discretionary account. See “Plan of Distribution” and “Use of Proceeds and Hedging” in the accompanying prospectus supplement for PLUS. | |
| Validity of the PLUS | In the opinion of Davis Polk & Wardwell LLP, as special counsel to Morgan Stanley, when the PLUS offered by this pricing supplement have been executed and issued by Morgan Stanley and authenticated by the trustee pursuant to the Senior Debt Indenture, and delivered against payment as contemplated herein, such PLUS will be valid and binding obligations of Morgan Stanley, enforceable in accordance with their terms, subject to applicable bankruptcy, insolvency and similar laws affecting creditors’ rights generally, concepts of reasonableness and equitable principles of general applicability (including, without limitation, concepts of good faith, fair dealing and the lack of bad faith), provided that such counsel expresses no opinion as to the effect of fraudulent conveyance, fraudulent transfer or similar provision of applicable law on the conclusions expressed above. This opinion is given as of the date hereof and is limited to the federal laws of the United States of America, the laws of the State of New York and the General Corporation Law of the State of Delaware. In addition, this opinion is subject to customary assumptions about the trustee’s authorization, execution and delivery of the Senior Debt Indenture and its authentication of the PLUS and the validity, binding nature and enforceability of the Senior Debt Indenture with respect to the trustee, all as stated in the letter of such counsel dated March 24, 2011, which has been filed as an exhibit to a Current Report on Form 8-K by Morgan Stanley on March 24, 2011. |
| Contact: | Morgan Stanley clients may contact their local Morgan Stanley branch office or our principal executive offices at 1585 Broadway, New York, New York 10036 (telephone number (866) 477-4776). All other clients may contact their local brokerage representative. Third-party distributors may contact Morgan Stanley Structured Investment Sales at (800) 233-1087. |
This is a summary of the terms and conditions of the PLUS. We encourage you to read the accompanying prospectus supplement for PLUS and prospectus for this offering, which can be accessed via the hyperlinks on the front page of this document.
June 2011 Page 5
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
How PLUS Work
Payoff Diagram
The payoff diagram below illustrates the payment at maturity on the PLUS based on the following terms:
| Stated principal amount: | $1,000 per PLUS |
|---|---|
| Leverage factor: | 150% |
| Maximum payment at maturity: | $1,150 per PLUS (115% of the stated principal amount) |
PLUS Payoff Diagram
How it works
§ If the final index value is greater than the initial index value, then investors would receive the $1,000 stated principal amount plus 150% of the appreciation of the underlying index over the term of the PLUS, subject to the maximum payment at maturity. Under the terms of the PLUS, an investor would realize the maximum payment at maturity at a final index value of 110% of the initial index value.
§ If the underlying index appreciates 4%, the investor would receive a 6% return, or $1,060 per PLUS.
§ If the underlying index appreciates 20%, the investor would receive only the maximum payment at maturity of $1,150 per PLUS, or 115% of the stated principal amount.
§ If the final index value is less than or equal to the initial index value, the investor would receive an amount less than or equal to the $1,000 stated principal amount, based on a 1% loss of principal for each 1% decline in the underlying index.
§ If the underlying index depreciates 10%, the investor would lose 10% of its principal and receive only $900 per PLUS at maturity, or 90% of the stated principal amount.
June 2011 Page 6
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
Payment at Maturity
At maturity, investors will receive for each $1,000 stated principal amount of PLUS that they hold an amount in cash based upon the value of the underlying index, determined as follows:
If the final index value is greater than the initial index value :
$1,000 + Leveraged Upside Payment;
subject to the maximum payment at maturity of $1,150 for each PLUS,
If the final index value is less than or equal to the initial index value:
$1,000 X Index Performance Factor
Because the index performance factor will be less than or equal to 1.0, this payment will be less than or equal to $1,000 .
June 2011 Page 7
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
EFPlaceholder Risk Factors
The following is a non-exhaustive list of certain key risk factors for investors in the PLUS. For further discussion of these and other risks, you should read the section entitled “Risk Factors” in the accompanying prospectus supplement for PLUS and prospectus. We also urge you to consult your investment, legal, tax, accounting and other advisers in connection with your investment in the PLUS.
§ PLUS do not pay interest or guarantee return of principal. The terms of the PLUS differ from those of ordinary debt securities in that the PLUS do not pay interest nor guarantee payment of the principal amount at maturity. If the final index value is less than the initial index value, the payout at maturity will be an amount in cash that is less than the $1,000 stated principal amount of each PLUS by an amount proportionate to the decrease in the value of the underlying index, and may be zero.
§ Appreciation potential is limited. The appreciation potential of the PLUS is limited by the maximum payment at maturity of $1,150 per PLUS (115% of the stated principal amount). Although the leverage factor provides 150% exposure to any increase in the value of the underlying index on the valuation date above the initial index value, because the payment at maturity will be limited to 115% of the stated principal amount for the PLUS, any increase in the final index value over the initial index value by more than 10% will not further increase the return on the PLUS.
§ There are risks associated with investments in securities linked to the value of foreign equity securities. The component stocks of the underlying index have been issued by companies principally located or incorporated in Japan. Investments in securities, such as the PLUS, linked to the value of foreign equity securities such as those constituting the underlying index involve risks associated with the securities markets in foreign countries, such as Japan, including risks of volatility in those markets, governmental intervention in those markets and cross-shareholdings in companies in certain countries, including Japan. Also, there is generally less publicly available information about foreign companies than about U.S. companies that are subject to the reporting requirements of the Securities and Exchange Commission, and foreign companies are subject to accounting, auditing and financial reporting standards and requirements different from those applicable to U.S. reporting companies. The prices of securities issued in foreign markets such as Japan may be affected by political, economic, financial and social factors in those countries, or global regions, including changes in government, economic and fiscal policies and currency exchange laws. Local securities markets may trade a small number of securities and may be unable to respond effectively to increases in trading volume, potentially making prompt liquidation of holdings difficult or impossible at times. Moreover, the economies in such countries may differ unfavorably from the economy in the United States in such respects as growth of gross national product, rate of inflation, capital reinvestment, resources, self-sufficiency and balance of payment positions.
§ Market price influenced by many unpredictable factors. Several factors will influence the value of the PLUS in the secondary market and the price at which MS & Co. may be willing to purchase or sell the PLUS in the secondary market, including: the value, volatility and dividend yield of the underlying index, interest and yield rates, time remaining to maturity, geopolitical conditions and economic, financial, political and regulatory or judicial events and any actual or anticipated changes in our credit ratings or credit spreads. The level of the underlying index may be, and has recently been, volatile, and we can give you no assurance that the volatility will lessen. See “Historical Information” on page 13 . You may receive less, and possibly significantly less, than the stated principal amount per PLUS if you try to sell your PLUS prior to maturity.
§ The PLUS are subject to the credit risk of Morgan Stanley, and any actual or anticipated changes to its credit ratings or credit spreads may adversely affect the market value of the PLUS. You are dependent on Morgan Stanley's ability to pay all amounts due on the PLUS at maturity and therefore you are subject to the credit risk of Morgan Stanley. If Morgan Stanley defaults on its obligations under the PLUS, your investment would be at risk and you could lose some or all of your investment. As a result, the market value of the PLUS prior to maturity will be affected by changes in the market’s view of Morgan Stanley's creditworthiness. Any actual or anticipated decline in Morgan Stanley’s credit ratings or increase in the credit spreads charged by the market for taking Morgan Stanley credit risk is likely to adversely affect the market value of the PLUS .
§ Not equivalent to investing in the underlying index. Investing in the PLUS is not equivalent to investing in the underlying index or its component stocks. Investors in the PLUS will not have voting rights or rights to receive dividends or other distributions or any other rights with respect to stocks that constitute the underlying index.
§ Adjustments to the underlying index could adversely affect the value of the PLUS. The underlying index publisher may add, delete or substitute the stocks constituting the underlying index or make other methodological changes that could
June 2011 Page 8
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
change the value of the underlying index. The underlying index publisher may discontinue or suspend calculation or publication of the underlying index at any time. In these circumstances, the calculation agent will have the sole discretion to substitute a successor index that is comparable to the discontinued underlying index and will be permitted to consider indices that are calculated and published by the calculation agent or any of its affiliates.
§ The inclusion of commissions and projected profit from hedging in the original issue price is likely to adversely affect secondary market prices. Assuming no change in market conditions or any other relevant factors, the price, if any, at which MS & Co. is willing to purchase the PLUS at any time in secondary market transactions will likely be significantly lower than the original issue price, since secondary market prices are likely to exclude commissions paid with respect to the PLUS and the cost of hedging our obligations under the PLUS that are included in the original issue price. The cost of hedging includes the projected profit that our subsidiaries may realize in consideration for assuming the risks inherent in managing the hedging transactions. These secondary market prices are also likely to be reduced by the costs of unwinding the related hedging transactions. Our subsidiaries may realize a profit from the expected hedging activity even if investors do not receive a favorable investment return under the terms of the PLUS or in any secondary market transaction. In addition, any secondary market prices may differ from values determined by pricing models used by MS & Co., as a result of dealer discounts, mark-ups or other transaction costs.
§ The PLUS will not be listed on any securities exchange and secondary trading may be limited. The PLUS will not be listed on any securities exchange. Therefore, there may be little or no secondary market for the PLUS. MS & Co. may, but is not obligated to, make a market in the PLUS. Even if there is a secondary market, it may not provide enough liquidity to allow you to trade or sell the PLUS easily. Because we do not expect that other broker-dealers will participate significantly in the secondary market for the PLUS, the price at which you may be able to trade your PLUS is likely to depend on the price, if any, at which MS & Co. is willing to transact. If, at any time, MS & Co. were not to make a market in the PLUS, it is likely that there would be no secondary market for the PLUS. Accordingly, you should be willing to hold your PLUS to maturity .
§ Hedging and trading activity by our subsidiaries could potentially adversely affect the value of the PLUS. One or more of our subsidiaries have carried out, and will continue to carry out, hedging activities related to the PLUS (and possibly to other instruments linked to the underlying index or its component stocks), including trading in the stocks that constitute the underlying index as well as in other instruments related to the underlying index. Some of our subsidiaries also trade the stocks that constitute the underlying index and other financial instruments related to the underlying index on a regular basis as part of their general broker-dealer and other businesses. Any of these hedging or trading activities on or prior to the pricing date could have affected the initial index value and, therefore, could have increased the value at which the underlying index must close on the valuation date before an investor receives a payment at maturity that exceeds the stated principal amount of the PLUS. Additionally, such hedging or trading activities during the term of the PLUS, including on the valuation date, could adversely affect the value of the underlying index on the valuation date and, accordingly, the amount of cash an investor will receive at maturi ty, if any.
§ The calculation agent, which is a subsidiary of the issuer, will make determinations with respect to the PLUS. As calculation agent, MS & Co. has determined the initial index value, will determine the final index value and will calculate the amount of cash you receive at maturity, if any. Any of these determinations made by MS & Co., in its capacity as calculation agent, including with respect to the occurrence or non-occurrence of market disruption events and the selection of a successor index or calculation of the final index value in the event of a discontinuance of the underlying index, may adversely affect the payout to you at maturity.
§ The U.S. federal income tax consequences of an investment in the PLUS are uncertain. Please read the discussion under “Fact Sheet ― General Information ― Tax considerations” in this document and the discussion under “United States Federal Taxation” in the accompanying prospectus supplement for PLUS (together the “Tax Disclosure Sections”) concerning the U.S. federal income tax conseq uences of an investment in the PLUS . If the Internal Revenue Service (the “IRS”) were successful in asserting an alternative treatment, the timing and character of income on the PLUS might differ significantly from the tax treatment described in the Tax Disclosure Sections. For example, under one treatment, U.S. Holders could be required to accrue original issue discount on the PLUS every year at a “comparable yield” determined at the time of issuance and recognize all income and gain in respect of the PLUS as ordinary income. The issuer does not plan to request a ruling from the IRS regarding the tax treatment of the PLUS , and the IRS or a court may not agree with the tax treatment described in the Tax Disclosure Sections. On December 7, 2007, the Treasury Department and the IRS released a notice requesting comments on the U.S. federal income tax treatment of “prepaid forward contracts” and similar instruments, such as the PLUS. The notice focuses in particular on whether to require holders of these instruments to
June 2011 Page 9
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
accrue income over the term of their investment. It also asks for comments on a number of related topics, including the character of income or loss with respect to these instruments; whether short-term instruments should be subject to any such accrual regime; the relevance of factors such as the exchange-traded status of the instruments and the nature of the underlying property to which the instruments are linked; the degree, if any, to which income (including any mandated accruals) realized by non-U.S. investors should be subject to withholding tax; and whether these instruments are or should be subject to the “constructive ownership” regime, which very generally can operate to recharacterize certain long-term capital gain as ordinary income and impose an interest charge. While the notice requests comments on appropriate transition rules and effective dates, any Treasury regulations or other guidance promulgated after consideration of these issues could materially and adversely affect the tax consequences of an investment in the PLUS, possibly with retroactive effect. Both U.S. and Non-U.S. Holders should consult their tax advisers regarding the U.S. federal income tax consequences of an investment in the PLUS, including possible alternative treatments, the issues presented by this notice and any tax consequences arising under the laws of any state, local or foreign taxing jurisdiction.
June 2011 Page 10
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
Information about the Underlying Index
The Nikkei 225 Index. The Nikkei 225 Index is a stock index calculated, published and disseminated by Nikkei Inc., which we refer to as Nikkei, that measures the composite price performance of selected Japanese stocks. The Nikkei 225 Index currently is based on 225 underlying stocks trading on the Tokyo Stock Exchange, or the TSE, representing a broad cross-section of Japanese industries. Stocks listed in the First Section of the TSE are among the most actively traded stocks on the TSE. All 225 Nikkei underlying stocks are stocks listed in the First Section of the TSE. Nikkei rules require that the 75 most liquid issues be included in the Nikkei 225 Index. Nikkei first calculated and published the Nikkei 225 Index in 1970. For additional information about the Nikkei 225 Index, see the information set forth under “Annex A—Underlying Indices and Underlying Index Publishers Information—Nikkei 225 Index” in the accompanying prospectus supplement for PLUS.
License Agreement between Nikkei Digital Media, Inc. and Morgan Stanley. As of the original issue date, we will have received the consent of Nikkei Digital Media, Inc. to use and refer to the Nikkei 225 Index in connection with the PLUS. Nikkei, the publisher of the Nikkei 225 Index, has the copyright to the Nikkei 225 Index. All rights to the Nikkei 225 Index are owned by Nikkei. Nikkei has the right to change the contents of the Nikkei 225 Index and to cease compilation and publication of the Nikkei 225 Index. In addition, Nikkei has no relationship to us or the PLUS; it does not sponsor, endorse, authorize, sell or promote the PLUS, and has no obligation or liability in connection with the administration, marketing or trading of the PLUS or with the calculation of the return on your investment.
Historical Information
The following table sets forth the published high and low closing values, as well as end-of-quarter closing values, of the underlying index for each quarter in the period from January 1, 2006 through June 24, 2011. The closing value of the underlying index on June 24, 2011 was 9,678.71. We obtained the information in the table below from Bloomberg Financial Markets, without independent verification. The historical values of the underlying index should not be taken as an indication of future performance, and no assurance can be given as to the level of the underlying index on the valuation date.
| Nikkei 225 Index | High | Low | Period End |
|---|---|---|---|
| 2006 | |||
| First Quarter | 17,059.66 | 15,341.18 | 17,059.66 |
| Second Quarter | 17,563.37 | 14,218.60 | 15,505.18 |
| Third Quarter | 16,385.96 | 14,437.24 | 16,127.58 |
| Fourth Quarter | 17,225.83 | 15,725.94 | 17,225.83 |
| 2007 | |||
| First Quarter | 18,215.35 | 16,642.25 | 17,287.65 |
| Second Quarter | 18,240.30 | 17,028.41 | 18,138.36 |
| Third Quarter | 18,261.98 | 15,273.68 | 16,785.69 |
| Fourth Quarter | 17,458.98 | 14,837.66 | 15,307.78 |
| 2008 | |||
| First Quarter | 14,691.41 | 11,787.51 | 12,525.54 |
| Second Quarter | 14,489.44 | 12,656.42 | 13,481.38 |
| Third Quarter | 13,603.31 | 11,259.86 | 11,259.86 |
| Fourth Quarter | 11,368.26 | 7,162.90 | 8,859.56 |
| 2009 | |||
| First Quarter | 9,239.24 | 7,054.98 | 8,109.53 |
| Second Quarter | 10,135.82 | 8,351.91 | 9,958.44 |
| Third Quarter | 10,639.71 | 9,050.33 | 10,133.23 |
| Fourth Quarter | 10,638.06 | 9,081.52 | 10,546.44 |
| 2010 | |||
| First Quarter | 11,097.14 | 9,932.90 | 11,089.94 |
| Second Quarter | 11,339.30 | 9,382.64 | 9,382.64 |
| Third Quarter | 9,795.24 | 8,824.06 | 9,369.35 |
| Fourth Quarter | 10,370.53 | 9,154.72 | 10,228.92 |
| 2011 | |||
| First Quarter | 10,857.53 | 8,605.15 | 9,755.10 |
| Second Quarter (through June 24, 2011) | 10,004.20 | 9,351.40 | 9,678.71 |
June 2011 Page 11
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
Underlying Index Historical Performance Daily Closing Values January 1, 2006 to June 24, 2011
June 2011 Page 12
PLUS Based on the Value of the Nikkei 225 Index due July 27, 2012
Performance Leveraged Upside Securities SM
Where You Can Find More Information
Morgan Stanley has filed a registration statement (including a prospectus, as supplemented by the prospectus supplement for PLUS) with the Securities and Exchange Commission, or SEC, for the offering to which this pricing supplement relates. You should read the prospectus in that registration statement, the prospectus supplement for PLUS and any other documents relating to this offering that Morgan Stanley has filed with the SEC for more complete information about Morgan Stanley and this offering. You may get these documents without cost by visiting EDGAR on the SEC web site at . www.sec.gov. Alternatively, Morgan Stanley will arrange to send you the prospectus and the prospectus supplement for PLUS if you so request by calling toll-free 800-584-6837.
You may access these documents on the SEC web site at . www.sec.gov as follows:
EFPlaceholder Prospectus Supplement for PLUS dated December 22, 2009
EFPlaceholder Prospectus dated December 23, 2008
Terms used in this pricing supplement are defined in the prospectus supplement for PLUS or in the prospectus. As used in this pricing supplement, the “Company,” “we,” “us” and “our” refer to Morgan Stanley.
“Performance Leveraged Upside Securities SM ” and “PLUS SM ” are our service marks.
June 2011 Page 13